VHL and clear cell renal carcinoma: The most notable example would be the inactivation mutations of the von Hippel–Lindau tumour suppressor (VHL) gene which lead to the constitutive activation of HIF signalling and CAIX expression in clear cell renal cell cancers (ccRCCs) and the von Hippel–Lindau syndrome hemangioblastomas [95,96].